Alternative therapies for localized prostate cancer

Current Urology Reports

Volumn 4, Issue 3, 2003, Pages 216-220

  Beerlage, Harrie P ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Benign Prostatic Hyperplasia; Localize Prostate Cancer; Prostate Cancer; Radiat Oncol Biol Phys; Radical Prostatectomy

Indexed keywords

BRACHYTHERAPY; CATHETER ABLATION; CRYOSURGERY; HUMAN; MALE; PROSTATE TUMOR; REVIEW; ULTRASOUND THERAPY;

BRACHYTHERAPY; CATHETER ABLATION; CRYOSURGERY; HUMANS; MALE; PROSTATIC NEOPLASMS; ULTRASONIC THERAPY;

EID: 0042911879     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-003-0072-5     Document Type: Article

References (54)

1. Catalona WJ, Bigg SW: Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol 1990, 143:538–543.
2. Frohmuller H, Theiss M, Wirth MP: Radical prostatectomy for carcinoma of the prostate: long-term follow-up of 115 patients. Eur Urol 1991, 19:279–283.
3. Walsh PC.: Radical prostatectomy, preservation of sexual function, cancer control: the controversy. Urol Clin North Am 1987, 14:663–673.
4. Paulson DF: Radiotherapy versus surgery for localized prostatic cancer. Urol Clin North Am 1987, 14:675–684.
5. Gonder MJ, Soanes WA, Shulman S: Cryosurgical treatment of the prostate. Invest Urol 1966, 3:372–378.
6. Mack D, Jungwirth A, Adam U, et al.: Long-term follow-up after open perineal cryotherapy in patients with locally confined prostate cancer. Eur Urol 1997, 32:129–132.
7. Onik G, Cobb C, Cohen J, et al.: US characteristics of frozen prostate. Radiology 1988, 168:629–631.
8. Zippe CD: Cryosurgery of the prostate: techniques and pitfalls. Urol Clin North Am 1996, 23:147–163. DOI: 10.1016/S0094-0143(05)70300-1
9. Cohen JK, Miller RJ, Rooker GM, Shuman BA: Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results: Urology 1996, 47:395–401. DOI: 10.1016/S0090-4295(99)80459-2
10. Cohen JK, Miller RJ, Benoit R, et al.: Five-year outcome of PSA and biopsy following cryosurgery as primary treatment for localized prostate cancer. J Urol 1998, 159(suppl):252. DOI: 10.1097/00005392-199805000-00109
11. Cox RL, Crawford ED: Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology 1995, 45:932–935. DOI: 10.1016/S0090-4295(99)80110-1
12. Wong WS, Chinn DO, Chinn M, et al.: Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer 1997, 79:963–974. DOI: 10.1002/(SICI)1097-0142(19970301)79:5<963::AID-CNCR13>3.0.CO;2-0
13. Aus G, Bergdahl S, Hugosson J, Lundin SE: Stone formation in the prostatic urethra after cryotherapy for prostate cancer. Urology 1997, 50:615–617. DOI: 10.1016/S0090-4295(97)00312-9
14. Seigne JD, Pisters LL, von Eschenbach AC: Osteitis pubis as a complication of prostate cryotherapy. J Urol 1996, 156:182. DOI: 10.1016/S0022-5347(01)65986-X
15. Zisman A, Pantuck AJ, Cohen JK, Belldegrun AS: Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template: technique and preliminary results. Urology 2001, 58:988–993. The first paper on a new cryotherapy technique. The only chance for survival of this technique because all older techniques failed. DOI: 10.1016/S0090-4295(01)01422-4
16. Young HH, Frontz WA: Some new methods of treatment of carcinoma of the lower genitourinary tract with radium. Surg Gynaec Oncol Obstet 1922, 34:93–98.
17. Barringer BS: Radium in the treatment of carcinoma of the bladder and prostate: a review of one years work. JAMA 1917, 18:1227–1230.
18. Flocks RH, Kerr HD, Elkins HB, Culp DA: Treatment of carcinoma of the prostate by interstitial radiation with radioactive gold-198: a preliminary report. J Urol 1998, 68:510–522.
19. Whitmore WFJ, Hilaris B, Grabstald H: Retropubic implantation of iodine 125 in the treatment of prostatic cancer. J Urol 1972, 108:918–920.
20. Mitchell JB, Bedford JS: Dose-rate effects in synchronous mammalian cells in culture. II: a comparison of the life cycle of HeLa cells during continuous irradiation or multiple-dose fractionation. Radiat Res 1977, 71:547–560. DOI: 10.2307/3574623
21. Brix F, Quirin A, Kohr P: Optimization of combined brachyteletherapy by the modification technic. Strahlenther Onkol 1988, 164:474–483.
22. Donnelly BJ, Pedersen JE, Porter AT, McPhee MS: Iridium-192 brachytherapy in the treatment of cancer of the prostate. Urol Clin North Am 1991, 18:481–483.
23. Holm HH, Juul N, Pedersen JF, et al.: Transperineal 125-iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 1983, 130:283–286.
24. Blasko JC, Ragde H, Luse RW, et al.: Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am 1996, 23:633–650. DOI: 10.1016/S0094-0143(05)70342-6
25. Sylvester J, Blasko JC, Grimm P, Ragde H: Interstitial implantation techniques in prostate cancer. J Surg Oncol 1997, 66:65–75. DOI: 10.1002/(SICI)1096-9098(199709)66:1<65::AID-JSO13>3.0.CO;2-N
26. Grimm PD, Blasko JC, Ragde H, et al.: Does brachytherapy have a role in the treatment of prostate cancer? Hematol Oncol Clin North Am 1996, 10:653–673. DOI: 10.1016/S0889-8588(05)70359-2
27. Porter AT, Blasko JC, Grimm PD, et al.: Brachytherapy for prostate cancer. CA Cancer J Clin 1995, 45:165–178.
28. Sock RG, Stone NM, Wesson MF, De Wyngaert JK: A modified technique allowing interactive ultrasound-guided 3-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 1995, 32:219–225.
29. Roy JN, Wallner KE, Harrington PJ, et al.: A CT-based evaluation method for permanent implants: application to prostate. Int J Radiat Oncol Biol Phys 1993, 26:163–169.
30. Moerland MA, Wijrdeman HK, Beersma R, et al.: Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997, 37:927–933. DOI: 10.1016/S0360-3016(96)00575-5
31. Bolla M, Gonzalez D, Warde P, et al.: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997, 337:295–300. DOI: 10.1056/NEJM199707313370502
32. Ragde H, Kobb L, Elgamal A, et al.: Modern prostate brachytherapy: prostate specific antigen results in 219 patients with up to 12 years observed follow-up. Cancer 2000, 89:135–141. Brachytherapy series with very long follow-up. Very important paper because of the claim of equivalence with radical prostatectomy. DOI: 10.1002/1097-0142(20000701)89:1<135::AID-CNCR18>3.0.CO;2-#
33. Blasko J, Grimm P, Sylvester J, Cavanagh W: The role of external beam radiotherapy with 125I/103Pd brachytherapy for prostate cancer. Radiother Oncol 2000, 57:273–278. DOI: 10.1016/S0167-8140(00)00288-7
34. Blasko JC, Ragde H, Grimm PD: Transperineal ultrasoundguided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 1991, 137:113–118.
35. Stock RG, Stone NN, DeWyngaert JK, et al.: Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma. Cancer 1996, 77:2386–2392. DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
36. Stock RG, Kao J, Stone NN: Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 2001, 165:436–439. Clearly adresses quality-of-life issues after brachytherapy. Important argument in the discussion between surgery and alternative treatments. DOI: 10.1097/00005392-200102000-00020
37. Bates TS, Wright MP, Gillatt DA: Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire. Eur Urol 1998, 33:165–169. DOI: 10.1159/000019549
38. Gelet A, Chapelon JY, Margonari J, et al.: Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 1993, 7:249–253. DOI: 10.1089/end.1993.7.249
39. Beerlage HP, van Leenders G, Oosterhof GO, et al.: High intensity focused ultrasound (HIFU) followed after one to two weeks by radical retropubic prostatectomy: results of a prospective study. Prostate 1999, 31:41–46. One of very few papers in which real histopathologic changes of alternative treatments for prostate cancer (HIFU) were studied. Never done in other treatments except RITA. DOI: 10.1002/(SICI)1097-0045(19990401)39:1<41::AID-PROS7>3.0.CO;2-5
40. Gelet A, Chapelon JY, Bouvier R, et al.: Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 1996, 29:174–183.
41. Gelet A, Chapelon JY, Bouvier R, et al.: Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001, 40:124–129. DOI: 10.1159/000049761
42. Thüroff S, Chaussy C: High intensive focused ultrasound (HIFU) against localized prostate carcinoma (PC): an additive tool before hormonal ablation? Eur Urol 1998, 33(suppl 1):54.
43. Schulman CC, Zlotta AR: Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. Urology 1995, 45:28–33. DOI: 10.1016/S0090-4295(95)96260-3
44. Schulman CC, Zlotta AR: Transurethral needle ablation (TUNA): histopathological, radiological, and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia. Prog Clin Biol Res 1994, 386:479–486.
45. Bruskewitz R, Issa MM, Roehrborn CG, et al.: A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998, 159:1588–1593. DOI: 10.1097/00005392-199805000-00048
46. Zlotta AR, Djavan B, Matos C, et al.: Percutaneous transperineal radiofrequency ablation of prostate tumor: safety, feasibility and pathological effects on human prostate cancer. Br J Urol 1998, 81:265–275. One of very few papers in which real histopathologic changes of alternative treatments for prostate cancer (RITA) were studied. Never done in other treaments except HIFU.
47. Djavan B, Zlotta AR, Susani M, et al.: Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination. Urology 1997, 50:986–992. DOI: 10.1016/S0090-4295(97)00540-2
48. Fowler-FJ J, Barry MJ, Lu YG, et al.: Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–1990 (updated June 1993). Urology 1993, 42:622–629. DOI: 10.1016/0090-4295(93)90524-E
49. Murphy GP, Mettlin C, Menck H, et al.: National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Commission on Cancer. J Urol 1994, 152:1817–1819.
50. Jager GJ, Ruijter ET, van-de KC, et al.: Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997, 203:645–652.
51. Fukunaga JN, Sandler HM, McLaughlin PW, et al.: Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997, 38:311–317. DOI: 10.1016/S0360-3016(97)82499-6
52. Pollack A, Zagars GK: External beam radiotherapy for stage T1/T2 prostate cancer: How does it stack up? Urology 1998, 51:258–264. DOI: 10.1016/S0090-4295(97)00621-3
53. Walsh PC, Partin AW, Epstein JI: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994, 152:1831–1836.
54. Polascik TJ, Pound CR, DeWeese TL, Walsh PC: Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. Urology 1998, 51:884–889. Compares radical prostatectomy and brachytherapy from the surgeons standpoint. DOI: 10.1016/S0090-4295(98)00153-8